2026

Articles
Title
CSE Global: UOBKH Sees More Upside After Management Meeting
ANALYSTS SAY: Buy, Sell, Hold (21 Oct)
YANGZIJIANG: Three Bullish Brokers — DBS Now Has The Highest Target Price
ANALYSTS SAY: Buy, Sell, Hold (20 Oct)
ANALYSTS SAY: Buy, Sell, Hold (19 Oct)
YANGZIJIANG: Double Target-Price Upgrade by Brokers ($6.10, $6.00). Why?
ANALYSTS SAY: Buy, Sell, Hold (16 Oct)
iX BIOPHARMA: KGI Initiates Coverage With S$1.17 Target Price. Why Bullish?
ANALYSTS SAY: Buy, Sell, Hold (15 Oct)
ANALYSTS SAY: Buy, Sell, Hold (14 Oct)